CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene fix trial aims to tame rare immune disease
Disease control ENROLLING_BY_INVITATIONThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a genetic condition that weakens the immune system and leads to severe infections. Researchers take the patient's own stem cells, add a working copy of the faulty gene, and return the …
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Double transplant breakthrough offers hope for rare immune disorder patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new approach for people aged 5 to 45 with primary immune deficiencies and end-stage lung disease. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combined procedure is safe and can…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC